AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21606291 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation-based training
Number of subjects: 44
Study 21606291 — intervention group
Group type: COMPARATOR
Intervention: Didactic lecture
Number of subjects: 44
Study 19421167 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 score (0 to 2 based on predicted allele activities)
Number of subjects: 297
Study 16846819 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 12
Study 16846819 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 12
Study 16846819 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ETS)
Number of subjects: 12
Study 16846819 — intervention group
Group type: COMPARATOR
Intervention: Medications
Number of subjects: 12
Study 16846819 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure and Acupuncture
Number of subjects: 12
Study 15273005 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood induction without external attribution
Number of subjects: 0
Study 15273005 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood induction without external attribution
Number of subjects: 0
Study 15273005 — intervention group
Group type: COMPARATOR
Intervention: External attribution provided (for both positive and negative mood induction)
Number of subjects: 0
Study 11339442 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 microg folic acid daily
Number of subjects: 144
Study 11339442 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 microg folic acid daily
Number of subjects: 144
Study 11339442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 9148986 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic peritoneal lavage (DPL) with 1 L crystalloid
Number of subjects: 11
Study 8131364 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural surfactant extract (prophylactic administration)
Number of subjects: 2500
Study 8131364 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural surfactant extract (administration to infants with moderate to severe RDS)
Number of subjects: 2500
Study 3693585 — intervention group
Group type: EXPERIMENTAL
Intervention: Cibenzoline
Number of subjects: 19
Study 31352308 — intervention group
Group type: EXPERIMENTAL
Intervention: LINK LA peer navigation intervention
Number of subjects: 356
Study 31352308 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk drug use (methamphetamine, cocaine, opioids)
Number of subjects: 356
Study 31352308 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 356
Study 30097052 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayview site without mask
Number of subjects: 0
Study 30097052 — intervention group
Group type: COMPARATOR
Intervention: Bayview site with mask
Number of subjects: 0
Study 30097052 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to CO, UFP, and SO2
Number of subjects: 0
Study 30097052 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayview site exposures
Number of subjects: 0
Study 26741306 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior mini-implant group (AMG)
Number of subjects: 32
Study 26741306 — intervention group
Group type: COMPARATOR
Intervention: Posterior mini-implant group (PMG)
Number of subjects: 32
Study 25146296 — intervention group
Group type: EXPERIMENTAL
Intervention: Criticisms of the state, its leaders, and their policies
Number of subjects: 0
Study 25146296 — intervention group
Group type: EXPERIMENTAL
Intervention: Posts about real-world events with collective action potential
Number of subjects: 0
Study 22527337 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement injection stem (secondary cementing technique)
Number of subjects: 30
Study 22527337 — intervention group
Group type: COMPARATOR
Intervention: Conventional cemented stem (primary cementing technique)
Number of subjects: 30
Study 19326803 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary quality improvement program to reduce RFOs, including education programs, team training, simulation videos, and daily reminders.
Number of subjects: 0
Study 17846974 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone
Number of subjects: 20
Study 17846974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15327636 — intervention group
Group type: EXPERIMENTAL
Intervention: Training procedure to manipulate the strength of associations between pairs of words
Number of subjects: 0
Study 11075845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal civamide 20 microg
Number of subjects: 34
Study 11075845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal civamide 150 microg
Number of subjects: 34
Study 8938011 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory detection during saccades
Number of subjects: 0
Study 8938011 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch discrimination during saccades
Number of subjects: 0
Study 8938011 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory localisation during saccades
Number of subjects: 0
Study 8938011 — intervention group
Group type: COMPARATOR
Intervention: Auditory detection during periods of fixation
Number of subjects: 0
Study 8938011 — intervention group
Group type: COMPARATOR
Intervention: Pitch discrimination during periods of fixation
Number of subjects: 0
Study 8938011 — intervention group
Group type: COMPARATOR
Intervention: Auditory localisation during periods of fixation
Number of subjects: 0
Study 1411248 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium restriction
Number of subjects: 85
Study 4073084 — intervention group
Group type: EXPERIMENTAL
Intervention: ticarcillin plus clavulanic acid
Number of subjects: 93
Study 4073084 — intervention group
Group type: COMPARATOR
Intervention: cefoxitin
Number of subjects: 93
Study 3732891 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole gut irrigation and 5-aminosalicylic acid
Number of subjects: 18
Study 3732891 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (total parenteral nutrition and steroids)
Number of subjects: 18
Study 31659822 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT (internet-delivered cognitive behavioural therapy)
Number of subjects: 114
Study 31659822 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment-as-usual)
Number of subjects: 114
Study 29059146 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-RK
Number of subjects: 60
Study 29059146 — intervention group
Group type: COMPARATOR
Intervention: HA-JV
Number of subjects: 60
Study 29122230 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program (10 sessions)
Number of subjects: 37
Study 29122230 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive stimulation)
Number of subjects: 37
Study 26231624 — intervention group
Group type: EXPERIMENTAL
Intervention: Home CIMT
Number of subjects: 156
Study 26231624 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 156
Study 23279658 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal biacuplasty (IDB)
Number of subjects: 59
Study 23279658 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 59
Study 21930607 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir
Number of subjects: 75
Study 21930607 — intervention group
Group type: COMPARATOR
Intervention: Hyperimmune bovine colostrum (HIBC)
Number of subjects: 75
Study 21930607 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir + HIBC
Number of subjects: 75
Study 21930607 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 75
Study 18327413 — intervention group
Group type: EXPERIMENTAL
Intervention: Venowave
Number of subjects: 32
Study 18327413 — intervention group
Group type: COMPARATOR
Intervention: Control device
Number of subjects: 32
Study 16291600 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg etoricoxib once daily
Number of subjects: 102
Study 16291600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 16291600 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg rofecoxib once daily
Number of subjects: 102
Study 16291600 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 102
Study 16291600 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 102
Study 12603638 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 20 mg
Number of subjects: 1334
Study 12603638 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 1334
Study 12603638 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 80 mg
Number of subjects: 1334
Study 12603638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1334
Study 10924983 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended tangents technique
Number of subjects: 5
Study 10924983 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-field technique
Number of subjects: 5
Study 10924983 — intervention group
Group type: EXPERIMENTAL
Intervention: Partly wide tangents technique
Number of subjects: 5
Study 10924983 — intervention group
Group type: COMPARATOR
Intervention: Supraclavicular field matched to standard tangential fields
Number of subjects: 5
Study 9356095 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic intubation without airway endoscopy mask
Number of subjects: 144
Study 9356095 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberoptic intubation with airway endoscopy mask
Number of subjects: 144
Study 9356095 — intervention group
Group type: COMPARATOR
Intervention: Laryngoscopic intubation
Number of subjects: 144
Study 8229492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance of suprapubic bladder aspiration
Number of subjects: 0
Study 8229492 — intervention group
Group type: COMPARATOR
Intervention: Unguided aspiration
Number of subjects: 0
Study 3710013 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose diet (45 g of sucrose replacing 45 g of complex carbohydrate)
Number of subjects: 23
Study 3710013 — intervention group
Group type: COMPARATOR
Intervention: Control diet (high in fibre and low in fat)
Number of subjects: 23
Study 29803703 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 1144
Study 29803703 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 1144
Study 29803703 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1144
Study 29803703 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1144
Study 29803703 — intervention group
Group type: EXPERIMENTAL
Intervention: ALPS treatment group
Number of subjects: 1144
Study 29803703 — intervention group
Group type: EXPERIMENTAL
Intervention: Rearrest
Number of subjects: 1144
Study 29803703 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG waveform characteristics
Number of subjects: 1144
Study 27723781 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance (n = 50)
Number of subjects: 195
Study 27723781 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking (n = 108)
Number of subjects: 195
Study 27723781 — intervention group
Group type: COMPARATOR
Intervention: Strength/Stretching/Stability (SSS; n = 48)
Number of subjects: 195
Study 24359506 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 15 mg daily
Number of subjects: 45
Study 24359506 — intervention group
Group type: COMPARATOR
Intervention: Risperidone 4 mg daily
Number of subjects: 45
Study 22260988 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (one, two, or three doses at 1 month, 2 months, or 6 months intervals)
Number of subjects: 1631
Study 22260988 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (two or three doses)
Number of subjects: 1631
Study 22260988 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine (second or third doses)
Number of subjects: 1631
Study 22260988 — intervention group
Group type: COMPARATOR
Intervention: 4CMenB vaccine
Number of subjects: 1631
Study 22260988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1631
Study 20377741 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) injection
Number of subjects: 120
Study 20377741 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) injection
Number of subjects: 120
Study 17904629 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (phone- and mail-based physical activity maintenance intervention)
Number of subjects: 1049
Study 17904629 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1049
Study 17265699 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12534644 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (600 mg ethylsuccinate ester, three oral doses on day 1 and two doses on day 2)
Number of subjects: 30
Study 12534644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12534644 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (in patients with Child's grade C liver cirrhosis)
Number of subjects: 30
Study 10987609 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg
Number of subjects: 48
Study 10987609 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 48
Study 10987609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 9120119 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric air tonometry
Number of subjects: 20
Study 9120119 — intervention group
Group type: COMPARATOR
Intervention: Saline tonometry
Number of subjects: 20
Study 1460168 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholinergic stimulation with RS 86
Number of subjects: 90
Study 3883182 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (30 mg per day)
Number of subjects: 132
Study 3883182 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (1 g per day)
Number of subjects: 132
Study 31758080 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific regimen not detailed)
Number of subjects: 0
Study 27806879 — intervention group
Group type: EXPERIMENTAL
Intervention: Snake algorithm applied to subjects with carotid plaques
Number of subjects: 44
Study 27012848 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (phone- and web-based weight loss program)
Number of subjects: 105
Study 27012848 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 105
Study 25082605 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (monthly telephone interviews for six months)
Number of subjects: 914
Study 25082605 — intervention group
Group type: COMPARATOR
Intervention: Usual care (telephone interviews at three and six months)
Number of subjects: 914
Study 22963503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mA tDCS
Number of subjects: 19
Study 22963503 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mA tDCS
Number of subjects: 19
Study 18948032 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO (epoetin alfa, 500 IU/kg intravenously)
Number of subjects: 43
Study 18948032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 17886412 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interactions perceived as helpful (n=7)
Number of subjects: 22
Study 17886412 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interactions perceived as unhelpful (n=7)
Number of subjects: 22
Study 17886412 — intervention group
Group type: EXPERIMENTAL
Intervention: Social interactions perceived as both helpful and unhelpful (n=6)
Number of subjects: 22
Study 15039493 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 2
Study 15039493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 11257953 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg every 8 h
Number of subjects: 104
Study 11257953 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg every 8 h
Number of subjects: 104
Study 11257953 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 104
Study 9777899 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted, multi‐component disability prevention and disease self‐management program led by a geriatric nurse practitioner (GNP)
Number of subjects: 201
Study 9777899 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study 7870226 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Hemodialysis (NHD) at 36.5 degrees C
Number of subjects: 10
Study 7870226 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm Hemodialysis (WHD) at 38.5 degrees C
Number of subjects: 10
Study 7870226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Hemodialysis (CHD) at 34.5 degrees C
Number of subjects: 10
Study 7870226 — intervention group
Group type: EXPERIMENTAL
Intervention: All dialysate temperatures
Number of subjects: 10
Study 3346792 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (0.125 mg/kg intravenous dose)
Number of subjects: 28
Study 3346792 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (0.125 mg/kg four times a day for 24 hours)
Number of subjects: 28
Study 3346792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 3346792 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 28
Study 31157710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) plus peripheral ischemic retinal photocoagulation
Number of subjects: 48
Study 31157710 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB) alone
Number of subjects: 48
Study 29769088 — intervention group
Group type: EXPERIMENTAL
Intervention: Model of a priori consent for pragmatic comparative effectiveness trial
Number of subjects: 23
Study 29769088 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomisation to one of two comparable drugs during a routine consultation
Number of subjects: 23
Study 29769088 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic system randomising a patient to drug A or drug B
Number of subjects: 23
Study 29769088 — intervention group
Group type: EXPERIMENTAL
Intervention: Time constraints identified as a hurdle to conducting research
Number of subjects: 23
Study 29769088 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional time for enrolment during a usual consult
Number of subjects: 23
Study 29769088 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall acceptability of the model of a comparative effectiveness trial
Number of subjects: 23
Study 28535202 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic ventricular fibrillation
Number of subjects: 47
Study 28535202 — intervention group
Group type: COMPARATOR
Intervention: Beating-heart technique
Number of subjects: 47
Study 25881751 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg test formulation (one 400-mg tablet)
Number of subjects: 35
Study 25881751 — intervention group
Group type: COMPARATOR
Intervention: 100 mg reference formulation (four 100-mg tablets)
Number of subjects: 35
Study 24666765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (2.5 mg titrated to 5 mg or 5 mg)
Number of subjects: 255
Study 24666765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 24666765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (2.5 mg titrated to 5 mg or 5 mg) with IIEF-EF score ≥ 26
Number of subjects: 255
Study 24666765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (2.5 mg titrated to 5 mg or 5 mg) achieving minimal clinically important difference in IIEF-EF score
Number of subjects: 255
Study 23017061 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia exposure
Number of subjects: 0
Study 23017061 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 19546583 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day)
Number of subjects: 21
Study 19546583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 17725789 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education and physical activity intervention
Number of subjects: 2425
Study 17725789 — intervention group
Group type: COMPARATOR
Intervention: Usual health and physical education curriculum (Control)
Number of subjects: 2425
Study 15313383 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 30
Study 15313383 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DSRS) + splenic artery ligation (SAL)
Number of subjects: 30
Study 11798515 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine at 740 mg/m(2)
Number of subjects: 21
Study 11798515 — intervention group
Group type: COMPARATOR
Intervention: Control (no amifostine)
Number of subjects: 21
Study 9599337 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine plus metacycline
Number of subjects: 20
Study 9599337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9093983 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume nasogastric balanced polyethylene glycol electrolyte lavage (20 ml/kg/h) until the effluent was clear (n = 15)
Number of subjects: 29
Study 9093983 — intervention group
Group type: COMPARATOR
Intervention: Low-volume sodium phosphate solution (22.5-45 ml) separated by oral fluid intake (n = 14)
Number of subjects: 29
Study 2282101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (5 g of n‐3 fatty acids daily for 30 days)
Number of subjects: 26
Study 2282101 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 wheat germ oil capsules daily for 30 days)
Number of subjects: 26
Study 2282101 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 26
Study 2282101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 7023599 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed primary wound closure
Number of subjects: 122
Study 7023599 — intervention group
Group type: COMPARATOR
Intervention: Primary closure with topical ampicillin powder
Number of subjects: 122
Study 7023599 — intervention group
Group type: COMPARATOR
Intervention: Primary closure alone
Number of subjects: 122